Ewha Womans University Medical Center
Ewha Womans University Medical Center
Republic of Korea, Seoul
Paik Nam-sun
47 years of experience
accreditations :
Clinic is certified :
Basalioma treatment cost in Republic of Korea typically includes a consultation with an oncologist ranging from $28 to $100 and a histopathology revision which costs $200 to $400. Total expenses depend on the lesion size, surgical complexity, and clinic tier. Patients often find 30% to 50% savings compared to the United States. Seoul and Incheon are the primary hubs for this treatment.
Typical Basalioma Treatment Costs in Republic of Korea
Bookimed Expert Insight: Patients seeking high-precision outcomes should consider university-affiliated centers in Seoul. Seoul National University Hospital (SNUH) is ideal for complex cases. It reports the highest cancer treatment statistics in South Korea. For those prioritizing aesthetic results, Ewha Womans University Medical Center specializes in minimally invasive surgery. This approach uses small incisions to reduce scarring. Korea University Anam Hospital offers world-class robotic surgery for tumor removals. These technologies help patients avoid visible scars during reconstruction.
| Republic of Korea | Turkey | Austria | |
| Mohs microsurgery | from $2,200 | from $2,200 | from $4,000 |
| Wide excision of melanoma | - | from $4,000 | - |
| Cryodestruction | - | from $3,500 | from $4,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Basalioma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Basalioma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Basalioma treatment journey.
Dr. Paik Nam-sun is a world-renowned surgeon in the field of breast cancer, thyroid cancer, and surgical oncology. He is the first in South Korea to have successfully performed the breast conserving surgery and has authored a unique stomach cancer surgery that reduces the risk of gastroesophageal reflux disease. He is an expert in the diagnosis and management of breast cancer and a member of the Korean Society of Cancer Prevention and the Korean Cancer Association.
Dr. X is a highly experienced surgeon, currently serving as the Director of the Training and Education Committee of the Korean Surgical Society, the Director of Information Technology Committee of the Korean Society of Coloproctology, the Director of Surgical Affairs Board of the Korean Society of Gastroenterology, and the Vice President of the Korean Association of Robotic Surgeons. He has held several surgical demonstrations and trainings in various countries and holds a Ph.D. and M.S. in Surgery from Korea University and a Doctor of Medicine from the College of Medicine at Korea University.